AKT1 and neoplasm: We used whole‐genome sequencing of circulating tumor DNA (ctDNA) to obtain copy number alteration profiles from the plasma of patients with metastatic breast cancer receiving a combination of paclitaxel and LY2780301 (dual AKT/p70S6H inhibitor).